Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors.
Pereira AF, Lisboa MRP, de Freitas Alves BW, da Silva CMP, Dias DBS, de Menezes KLS, Cesário FRAS, de França JC, de Oliveira AR, Hallak JEC, Zuardi AW, Crippa JA, de Alencar NMN, Lima-Júnior RCP, Vale ML. Pereira AF, et al. Among authors: hallak jec. Neurotox Res. 2021 Dec;39(6):1782-1799. doi: 10.1007/s12640-021-00442-x. Epub 2021 Nov 18. Neurotox Res. 2021. PMID: 34792764
Effects of cannabidiol (CBD) on regional cerebral blood flow.
Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JE, McGuire PK, Filho Busatto G. Crippa JA, et al. Neuropsychopharmacology. 2004 Feb;29(2):417-26. doi: 10.1038/sj.npp.1300340. Neuropsychopharmacology. 2004. PMID: 14583744 Clinical Trial.
Accuracy of psychiatric diagnosis performed under indirect supervision.
Del-Ben CM, Hallak JE, Sponholz A Jr, Marques JM, Labate CM, Contel JO, Zuardi AW. Del-Ben CM, et al. Braz J Psychiatry. 2005 Mar;27(1):58-62. doi: 10.1590/s1516-44462005000100013. Epub 2005 Apr 18. Braz J Psychiatry. 2005. PMID: 15867985 Free article.
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JE. Crippa JA, et al. J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9. J Psychopharmacol. 2011. PMID: 20829306 Clinical Trial.
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.
Uribe-Mariño A, Francisco A, Castiblanco-Urbina MA, Twardowschy A, Salgado-Rohner CJ, Crippa JA, Hallak JE, Zuardi AW, Coimbra NC. Uribe-Mariño A, et al. Neuropsychopharmacology. 2012 Jan;37(2):412-21. doi: 10.1038/npp.2011.188. Epub 2011 Sep 14. Neuropsychopharmacology. 2012. PMID: 21918503 Free PMC article.
269 results